Android Apple

Pfizer Gets European Approval of Hympavzi Hemophilia Drug

By MarketWatch   |   1 month ago
Pfizer Gets European Approval of Hympavzi Hemophilia Drug

Pfizer's Hympavzi has gained approval from the European Commission for preventing bleeding in patients with severe hemophilia A or B.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.